KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine

• Autores principales: Wei Song (Autor), Heng Zhang (Autor), Yi Lu (Autor), Houliang Zhang (Autor), Jinliang Ni (Autor), Lan Chang (Autor), Yongzhe Gu (Autor), Guangchun Wang (Autor), Tianyuan Xu (Autor), Zonglin Wu (Autor), Keyi Wang (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Patients diagnosed with papillary renal cell carcinoma (pRCC) exhibit a high rate of clinical metastasis; however, the underlying molecular mechanism is unclear. In this study, KH-type splicing regulatory protein (KHSRP) participated in pRCC progression and was associated with metastasis. It was pos...